XM does not provide services to residents of the United States of America.
I
I

ITV

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK wins fight against EU tax order, in setback for EU's Vestager

UPDATE 1-UK wins fight against EU tax order, in setback for EU's Vestager Adds background information throughout, court quote in paragraphs 5,6 By Foo Yun Chee BRUSSELS, Sept 19 (Reuters) - Britain won on Thursday its fight against an EU order to recover millions of euros from the London Stock Exchange LSEG.L , broadcaster ITV ITV.L and other multinationals, in a setback to EU regulators' crackdown on certain tax schemes.
A
D
I
I
P

EU top court backs UK appeal against EU order to recover mlns in state aid

EU top court backs UK appeal against EU order to recover mlns in state aid BRUSSELS, Sept 19 (Reuters) - Europe's top court on Thursday sided with Britain in its fight against an EU order to recover millions of euros from the London Stock Exchange LSEG.L , ITV ITV.L , and other multinationals that EU regulators said benefited from an illegal exemption in a UK tax scheme.
I

UK's ITV falls on lower HY revenue

BUZZ-UK's ITV falls on lower HY revenue ** Shares of British broadcaster ITV ITV.L down 5.7% at 79.55p ** Total rev fell 3% to 1.90 bln pounds in H1 with ITV studios total rev down 13% ** Growth in total ad rev of 10% offset by the expected decline in ITV studios rev ** Chief Carolyn McCall says growth in ad rev was driven by "a very successful Eur
I

ITV CEO says the ad market is 'very firm'

BRIEF-ITV CEO says the ad market is 'very firm' July 25 (Reuters) - ITV PLC ITV.L : ITV CEO SAYS THE AD MARKET AT THE MOMENT IS VERY FIRM ITV CEO SAYS WE HAD A GOOD LIFT FROM THE EUROS IN JUNE, AND FROM THE FEW MATCHES IN JULY Further company coverage: ITV.L (Reporting By London Bureau)
I

UK Stocks-Factors to watch on July 25

UPDATE 1-UK Stocks-Factors to watch on July 25 Adds new items, updates futures July 25 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.6%. * ASTRAZENECA: Anglo-Swedish drugmaker AstraZeneca AZN.L raised its sales and profit forecasts for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases.
A
B
B
C
I
L
V
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.